Fig. 3From: Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4ʹ,3ʹ:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitorsSome pyrazolo[1,5-a]pyrimidines such as I–III with a standard drug dinaciclib as anticancer agentsBack to article page